This whitepaper outlines how the collaboration of organizations across science-based industries and their leveraging of advanced technology will improve lab processes and productivity. Digitalization will accelerate scientific creativity, bringing better products to market faster. Together these trends will not just benefit science but enable better care for patients as well.
With the rapid adoption of cloud computing, learn how Thermo Scientific™ Chromeleon™ CDS supports moving from a traditional on-premise setup to a cloud based deployment and associated benefits and challenges.
21 CFR Part 11 requires Food and Drug Administration (FDA)-regulated industries, including medical device manufacturers, drug makers, biotech companies and biologics developers, to have validation documentation and implement controls such as audit trails and electronic signatures
R&D-driven industries talk a lot about progressing towards the paperless laboratory. The ultimate aim is to capture and store all experimental, process, inventory and results data, from the earliest stages of discovery, through to manufacturing, QA/QC and even instrument management, in an electronic format
Data governance is an integral part of a regulated company’s quality system. Having a chromatography data system can simplify system administration and ensure regulatory compliance (including 21 CFR Part 11) and adherence to data integrity guidelines.
Robert Roe looks at the changing ways that the HPC industry uses cloud computing technology
Robert Roe reports on new technology and 30 years of the US supercomputing conference at SC18 in Dallas
Sophia Ktori completes her two-part series on the use of artificial intelligence in healthcare research
Robert Roe reports on developments in multiphysics simulation at the Global Altair Technology Conference
Gemma Church reveals how simulation and modelling are aiding the design and development of a range of medical devices